1.Brachial plexus injury during playing golf.
Young Jin KO ; Hyoung Sheen KIM ; Sae Yoon KANG ; Kyoung Mook SEO
Journal of the Korean Academy of Rehabilitation Medicine 1993;17(4):649-655
No abstract available.
Brachial Plexus*
;
Golf*
2.Review of regulatory management on standards and specifications for veterinary medical devices in Korea.
Kyoung Mook KANG ; Tae Won KIM ; Oh Ryun KWON ; Hea Jung PARK ; Soo Min CHO ; Chung Hyun KIM ; Myoung Heon LEE ; Jin San MOON
Korean Journal of Veterinary Research 2017;57(2):71-78
Well-established standards and specifications for medical devices not only provide clarity and consistency in licensing processes but also secure device safety and effectiveness. This study reviewed regulatory standards and specifications for veterinary medical devices in Korea based on data obtained through analyses of those medical devices. General standards for electromechanical, electromagnetic, and biological safety and individual standards for 76 electric and 70 general medical device products have been established by the Korean Ministry of Food and Drug Safety. However, the first standards and specifications for veterinary medical devices were established in March 2000 for two products (disposable needle and syringe). Similar to the large number of standards for medical devices, there have been general standards for safety and individual standards for 72 veterinary medical devices (27 electric medical devices, 12 non-electric medical devices, 10 medical supplies, and 23 other types) established since 2014. These new standards considered, among other aspects, the devices' applications, usage characteristics, and industrial environment. To date, the establishment of standards and specifications for veterinary medical devices remains limited. This study suggests that improvements should be made to the regulation of general and individual standards associated with various veterinary medical instruments, supplies, and in vitro diagnostic medical reagents.
Equipment and Supplies
;
Equipment Safety
;
In Vitro Techniques
;
Indicators and Reagents
;
Korea*
;
Licensure
;
Magnets
;
Needles
3.Enhancement of Gastric Ulcer Healing and Angiogenesis by Cochinchina Momordica Seed Extract in Rats.
Jung Mook KANG ; Nayoung KIM ; Bongcheol KIM ; Joo Hyon KIM ; Bong Yong LEE ; Ji Hyun PARK ; Mi Kyoung LEE ; Hye Seung LEE ; Joo Sung KIM ; Hyun Chae JUNG ; In Sung SONG
Journal of Korean Medical Science 2010;25(6):875-881
Cochinchina momordica seed is the dried ripe seed of Momordica cochinchinensis, a perennial vine. The antiulcer effect of an extract from cochinchina momordica seeds (SK-MS10) was evaluated in a rat model of acetic acid-induced gastric ulcers. Gastric ulcers were produced by subserosal injection of acetic acid. SK-MS10 (200 mg/kg) or vehicle was administered orally once per day for 14 days after the acetic acid injection. The stomach was removed and the ulcer size measured at day 7 and 14 of the treatment. Expression of vascular endothelial growth factor (VEGF) was assessed by real-time RT-PCR and Western blot analysis. In addition, the microvasculature density (MVD) adjacent to the ulcer margin was examined by immunohistochemistry. The treatment with SK-MS10 for 7 and 14 days significantly accelerated ulcer healing and increased the expression of mRNA (at day 7) as well as VEGF protein (at day 14) compared to the vehicle-treated rats. The MVD for factor VIII was also higher in the SK-MS10 treatment group compared to the vehicle-treated rats; however, these differences were not statistically significant. These results suggest that SK-MS10 treatment accelerates the healing of gastric ulcers via upregulation of VEGF and angiogenesis in an acetic acid rat model.
4.Percutaneous transluminal coronary angioplasty (PTCA) in the elderly: acute and follow-up angiographic results.
Kwang Il KIM ; Hyun Jae KANG ; Kyoung Hoon YOU ; Young Seok CHO ; In Ho CHAE ; Hyo Soo KIM ; Cheol Ho KIM ; Dae Won SOHN ; Byung Hee OH ; Myoung Mook LEE ; Young Bae PARK ; Yun Shik CHOI ; Young Woo LEE
Journal of the Korean Geriatrics Society 1998;2(1):35-41
BACKGROUND: Coronary artery disease is a major problem and one of the most common cause of death in the elderly. With an increase in technical success rate and a reduction in short-term complication rates for coronary angioplasty, PTCA seems to be an attractive therapy for the elderly. But elderly patients have more extensive coronary artery disease and frequently associated with other disease such as diabetes. So, it was reported that the longterm clinical and angiographic outcome is unfavorable. We examined clinical characteristic and angiographic outcome according to age of patients who underwent balloon angioplasty. METHODS: We studied total 68 patients who underwent balloon angioplasty for the treatment of reversible ischemia and all patients underwent follow-up angiography. Patients were divided into 2 groups according to age; those <65 years (n=49) and those > = or65 years (n=19). Baseline characteristics and angiographic findings, follow-up angiographic findings were compared between two groups. RESULTS: Female sex was more prevalent in the elderly group. Clinical diagnosis and comorbid state were not different. Procedure time was longer in the elderly group (88.1+/-24.5 min vs 75.3+/-21.2 min, p<0.05), but hospital stay was not different. In elderly group, residual stenosis after angioplasty was greater than in younger group (32.9+/-12.7% vs 26.4+/-10.6%, p<0.05). But immediate success and restenosis rate at follow-up angiography had no significant difference between groups. CONCLUSION: PTCA can be done safely and successfully in the elderly and the initial gain is maintained at follow-up angiography. So in symptomatic elderly patients of coronary artery disease, PTCA can play an important role for symptomatic relief.
Aged*
;
Angiography
;
Angioplasty
;
Angioplasty, Balloon
;
Angioplasty, Balloon, Coronary*
;
Cause of Death
;
Constriction, Pathologic
;
Coronary Artery Disease
;
Diagnosis
;
Female
;
Follow-Up Studies*
;
Humans
;
Ischemia
;
Length of Stay
5.Effects of Genetic Polymorphisms of Glutathione S-transferase P1 on Helicobacter pylori-associated Gastric Cancer.
Jung Mook KANG ; Nayoung KIM ; Sung Il CHO ; Dong Ho LEE ; Young Soo PARK ; Yu Rim KIM ; Ji Hyun PARK ; Mi Kyoung LEE ; Joo Sung KIM ; Hyun Chae JUNG ; In Sung SONG
Gut and Liver 2008;2(1):23-29
BACKGROUND/AIMS: Glutathione S-transferase P1 (GSTP1) scavenges radicals via its peroxidase activity. The purpose of this study was to determine the association of GSTP1 genetic polymorphisms with the expression of H. pylori-associated gastroduodenal disease. METHODS: This study involved 1,911 subjects, comprising patients with four diseases (gastric cancer, dysplasia, benign gastric ulcer, and duodenal ulcer disease) and controls. Biallelic polymorphisms were genotyped by restriction fragment length polymorphism techniques. RESULTS: The frequency of the genetic polymorphism at nucleotide 313 of GSTP1 did not differ among the five study groups. However, when the gastric cancer group was subdivided into advanced gastric cancer (AGC) and early gastric cancer, the frequency of the G/G genotype was significantly higher in the AGC group than in all the control subgroups (OR: 1.2, 95% CI: 1.1-4.9). The frequency of this genotype differed significantly in the H. pylori-positive AGC group (OR: 2.7, 95% CI: 1.1-6.3) but not in the H. pylori-negative group. Furthermore, the difference was greater in the intestinal type, and was not found in diffuse types of disease. CONCLUSIONS: This study found that genetic polymorphisms of GSTP1 were associated with H. pylori-associated gastric cancer only during the advanced stage of gastric cancer, with intestinal-type histology evident in H. pylori-positive subjects.
Duodenal Ulcer
;
Genotype
;
Glutathione
;
Glutathione Transferase
;
Helicobacter
;
Helicobacter pylori
;
Humans
;
Peroxidase
;
Polymorphism, Genetic
;
Polymorphism, Restriction Fragment Length
;
Stomach Neoplasms
;
Stomach Ulcer
6.Risk Factors for Development and Recurrence of Peptic Ulcer Disease.
Jin Joo KIM ; Nayoung KIM ; Byoung Hwan LEE ; Jung Mook KANG ; Pyoungju SEO ; Min Kyoung LIM ; Jung Hee KWON ; Byeong Jun SONG ; Jung Won LEE ; Sang Hyup LEE ; Young Soo PARK ; Jin Hyeok HWANG ; Jin Wook KIM ; Sook Hyang JEONG ; Dong Ho LEE ; Hyun Chae JUNG ; In Sung SONG
The Korean Journal of Gastroenterology 2010;56(4):220-228
BACKGROUND/AIMS: Peptic ulcer disease (PUD) is one of the common gastrointestinal diseases, and its medical management has been developed so much that the incidence of its serious complications, such as bleeding and perforation, are declining significantly. Its prevalence in Korea is not definitely decreased, probably due to increasing proportion of elderly patients and their rising usage of non-steroidal anti-inflammatory drugs (NSAIDs) and aspirins. This study was conducted to identify the risk factors for development and recurrence of peptic ulcer disease in Korea. METHODS: From 2003 to 2008, upper gastrointestinal endoscopy and detailed personal questionnaires were performed for patients who visited Department of Gastroenterology at Seoul National University Bundang Hospital. In total, 475 PUD patients and 335 non-ulcer dyspepsia patients were included. The results of questionnaires and repeated upper gastrointestinal endoscopy at initial diagnosis time and follow-up periods were analyzed. RESULTS: Multivariable analysis showed that male, H. pylori infection, NSAIDs use and smoking were risk factors for the development of PUD. The use of proton pump inhibitors (PPIs) and H2 receptor antagonists has significantly reduced the risk of PUD in patients who had taken NSAIDs and/or aspirins. H. pylori infection was found as the only risk factor for the recurrence of PUD. CONCLUSIONS: For the old patients who are taking drugs, such as NSAIDs and aspirins, concomitant use of PPIs or H2 receptor antagonists should be considered to protect from the development of PUD. H. pylori eradication has been confirmed again to be essential for the treatment of PUD patients infected with H. pylori.
Adult
;
Aged
;
Anti-Inflammatory Agents, Non-Steroidal/therapeutic use
;
Aspirin/therapeutic use
;
Endoscopy, Gastrointestinal
;
Female
;
Helicobacter Infections/complications/drug therapy
;
Helicobacter pylori
;
Histamine H2 Antagonists/therapeutic use
;
Humans
;
Male
;
Middle Aged
;
Peptic Ulcer/drug therapy/*etiology
;
Proton Pump Inhibitors/therapeutic use
;
Questionnaires
;
Recurrence
;
Risk Factors
;
Sex Factors
;
Smoking
;
Stomach Ulcer/etiology